Skip to main content

Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation-evidence from the United States and Japan.

Publication ,  Journal Article
Okumura, K; Inoue, H; Yasaka, M; Gonzalez, JM; Hauber, AB; Levitan, B; Yuan, Z; Briere, J-B
Published in: Value Health Reg Issues
May 2015

OBJECTIVES: Atrial fibrillation (AF) is a factor in the development of thrombi that can lead to ischemic strokes. Anticoagulants are crucial in preventing strokes among patients with AF but are associated with bleeding risks. Recent studies have shown that despite anticoagulants' efficacy in stroke prevention, many patients with AF receive subtherapeutic levels of anticoagulation because of concerns about bleeding. Of particular interest is to quantify the perceived relative importance of treatment-related benefits and risks and how these perceptions vary between patients and physicians in different countries. METHODS: Patients' and physicians' preferences were elicited using a discrete-choice experiment. We evaluated disagreements in preferences for the benefits and risks of anticoagulants. RESULTS: A total of 186 patients with AF and 107 physicians in the United States completed the survey. In Japan, 152 patients and 164 physicians completed the same survey. Japanese patients were relatively less averse than US patients to bleeding risks. Physicians in both countries did not distinguish between nondisabling and disabling strokes. US patients were less tolerant than physicians of nonmajor clinically relevant bleeding risk when this risk was a consequence of preventing nondisabling strokes. Japanese patients were generally more tolerant than physicians of bleeding risks when the risks were consequences of preventing both nondisabling and disabling strokes. CONCLUSIONS: Overall, preferences for anticoagulant benefits and risks were not statistically different between patients and physicians in the United States, nor were there differences in preferences for different stroke risks between physicians in the United States and Japan; however, preferences were different between patients and physicians in Japan.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Value Health Reg Issues

DOI

EISSN

2212-1102

Publication Date

May 2015

Volume

6

Start / End Page

65 / 72

Location

United States

Related Subject Headings

  • 4407 Policy and administration
  • 4203 Health services and systems
  • 3801 Applied economics
  • 1402 Applied Economics
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Okumura, K., Inoue, H., Yasaka, M., Gonzalez, J. M., Hauber, A. B., Levitan, B., … Briere, J.-B. (2015). Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation-evidence from the United States and Japan. Value Health Reg Issues, 6, 65–72. https://doi.org/10.1016/j.vhri.2015.03.016
Okumura, Ken, Hiroshi Inoue, Masahiro Yasaka, Juan Marcos Gonzalez, A Brett Hauber, Bennett Levitan, Zhong Yuan, and Jean-Baptiste Briere. “Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation-evidence from the United States and Japan.Value Health Reg Issues 6 (May 2015): 65–72. https://doi.org/10.1016/j.vhri.2015.03.016.
Okumura K, Inoue H, Yasaka M, Gonzalez JM, Hauber AB, Levitan B, et al. Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation-evidence from the United States and Japan. Value Health Reg Issues. 2015 May;6:65–72.
Okumura, Ken, et al. “Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation-evidence from the United States and Japan.Value Health Reg Issues, vol. 6, May 2015, pp. 65–72. Pubmed, doi:10.1016/j.vhri.2015.03.016.
Okumura K, Inoue H, Yasaka M, Gonzalez JM, Hauber AB, Levitan B, Yuan Z, Briere J-B. Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation-evidence from the United States and Japan. Value Health Reg Issues. 2015 May;6:65–72.

Published In

Value Health Reg Issues

DOI

EISSN

2212-1102

Publication Date

May 2015

Volume

6

Start / End Page

65 / 72

Location

United States

Related Subject Headings

  • 4407 Policy and administration
  • 4203 Health services and systems
  • 3801 Applied economics
  • 1402 Applied Economics
  • 1117 Public Health and Health Services
  • 1115 Pharmacology and Pharmaceutical Sciences